Dr Sharissa Latham

Dr Sharissa Latham completed her PhD with Dr Valery Combes and Professor Georges Grau at the University of Sydney in 2015, where she studied the role of the actin cytoskeleton in extracellular vesicle shedding and specialised in advanced imaging methodologies incorporating both light and electron microscopy. Following her PhD, Sharissa commenced postdoctoral studies with Professor Dietmar Manstein at Hannover Medical School, Germany, where she investigated the role of actomyosin complexes in intracellular trafficking, sarcomere assembly and rare diseases. During this time, Sharissa co-led a study that characterised a previously undescribed actin-based disease, named ACTB-Associated Syndromic Thrombocytopenia (Latham et al., 2018, Nature Communications).

Sharissa returned to Australia in 2018 to join Dr David Croucher in the Network Biology Group at the Garvan Institute of Medical Research. Building on her experience in cytoskeletal biology and advanced imaging approaches, Sharissa’s research aims to develop novel therapeutic approaches that target actin-microtubule crosstalk for the treatment of triple negative breast cancers.